IL12A (rs485497) (Fig 2) was associated with decreased risk in FL, as well as outcome in DLBCL and we also confirmed the earlier suggested association between B-NHL outcome and the CX3CR1 gene [47] (Fig 3) and we did observe a novel association between the IL5 (rs2069812), encoding B-cell growth factor IL-5 [48], and outcome of DLBCL ((HR = 1.94 (1.12–3.39)) for carriers of the TT genotype, Fig 4). This evidence concerns the gene IL5 and diffuse large B-cell lymphoma.